Halozyme
HALO
508 hedge funds and large institutions have $7.17B invested in Halozyme in 2024 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 180 increasing their positions, 168 reducing their positions, and 41 closing their positions.
124% more first-time investments, than exits
New positions opened: 92 | Existing positions closed: 41
82% more call options, than puts
Call options by funds: $23.1M | Put options by funds: $12.7M
12% more capital invested
Capital invested by funds: $6.4B → $7.17B (+$764M)
10% more funds holding
Funds holding: 460 → 508 (+48)
2.83% more ownership
Funds ownership: 96.08% → 98.91% (+2.8%)
7% more repeat investments, than reductions
Existing positions increased: 180 | Existing positions reduced: 168
55% less funds holding in top 10
Funds holding in top 10: 11 → 5 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$114M |
| 2 |
Goldman Sachs
New York
|
+$68.6M |
| 3 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$55.2M |
| 4 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$49.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$46.7M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$40.7M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$33.5M |
| 4 |
EIP
Epoch Investment Partners
New York
|
-$33.4M |
| 5 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$23.9M |
HALO Hedge Fund Activity: Q3 2024 in Review
508 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q3 2024, worth a combined $7.17B — up 12% from $6.4B a quarter earlier.
Buyers outnumbered sellers: 92 funds opened new HALO positions and 41 closed out — a net gain of 51 holders — while 180 added to existing stakes and 168 trimmed.
The largest buyer was Congress Asset Management, adding an estimated $114M. The largest seller was TD Asset Management, cutting an estimated $46.7M.
- 508 institutional investors held Halozyme (HALO) as of Q3 2024, up from 460 in Q2 2024.
- Funds reported $7.17B of Halozyme stock for Q3 2024, up 12% quarter-over-quarter.
- 92 funds opened new Halozyme positions in Q3 2024 and 41 closed out, a net change of +51 holders.
- The largest Halozyme buyer in Q3 2024 was Congress Asset Management, an estimated $114M added.
- The largest Halozyme seller in Q3 2024 was TD Asset Management, an estimated $46.7M sold.
Based on aggregated 13F filings for Q3 2024.